The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Breast Cancer Index re-stratifies 21-gene assay risk groups for late distant recurrence and extended endocrine therapy benefit: Results from the BCI Registry Study.
 
Valerie Chuy
No Relationships to Disclose
 
Natalia Siuliukina
Employment - Biotheranostics; io9, LLC (I)
Stock and Other Ownership Interests - Genome Insight (I); Hologic; io9, LLC (I)
Honoraria - Genome Insight (I); io9, LLC (I)
Consulting or Advisory Role - Genome Insight (I); io9, LLC (I)
Patents, Royalties, Other Intellectual Property - UCSD Genomics Program Talk (I)
 
Brandon O'Neal
Employment - Biotheranostics
Stock and Other Ownership Interests - Hologic
 
Amanda Kristine Laust Anderson
Employment - Biotheranostics
Stock and Other Ownership Interests - Hologic
 
Kent Hoskins
Employment - Lilly (I)
Research Funding - Abbvie (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Agendia
Other Relationship - Agendia
 
Yi Zhang
Employment - Biotheranostics
Stock and Other Ownership Interests - Hologic
Patents, Royalties, Other Intellectual Property - bioTheranostics
Travel, Accommodations, Expenses - Biotheranostics
 
Kai Treuner
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
Patents, Royalties, Other Intellectual Property - Related to research conducted at Biotheranostics, Inc.
Travel, Accommodations, Expenses - bioTheranostics
 
VK Gadi
Stock and Other Ownership Interests - 3rdEyeBio; Emerging Markets Cancer Ignition Fund; New Equilibrium Biosciences; Novilla; Phoenix Molecular Designs; Sengine precision medicine; Tahoma Therapeutics
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Hologic; Puma Biotechnology; Seagen/Pfizer; Stemline Therapeutics
Speakers' Bureau - Hologic; Puma Biotechnology; Seagen; Stemline Therapeutics
Research Funding - Agendia (Inst); Illumina; Tizona Therapeutics, Inc.
Travel, Accommodations, Expenses - Genentech/Roche; Puma Biotechnology; Seagen